IP Library Granted Patent US 10,337,056
Granted Patent B2
US 10,337,056 · App. 15/493,341 · Granted Jul 2, 2019

Dynamic flux nucleic acid sequence amplification

Inventor: Brian Erich Caplin (Park City, UT)
C12Q1/6858C12Q1/689C12Q1/6816C12Q1/6825C12Q1/6827C12Q1/6844C12Q1/6846C12Q1/6848C12Q1/6876C12Q1/6886C12Q1/703C12Q2600/106C12Q2600/136C12Q2600/156
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,337,056
App. No.
15/493,341
Granted
Jul 2, 2019
Kind
B2
Abstract

Provided herein are dynamic flux nucleic acid sequence amplification methods. The dynamic flux nucleic acid sequence amplification methods described herein are capable of amplifying nucleic acid sequences within a narrow temperature range. In some aspects, the disclosure provides for real-time dynamic flux nucleic acid sequence amplification methods.

Claims (15)

1. A real-time dynamic flux method of nucleic acid sequence amplification, comprising:

a. combining a pair of forward and reverse oligonucleotide primers with a target nucleic acid sequence to be amplified; and

b. amplifying the target nucleic acid sequence by thermocycling the pair of forward and reverse oligonucleotide primers and the target nucleic acid sequence within a 15° C. temperature range defined by the melting temperature of the oligonucleotide primers and the melting temperature of the target nucleic acid sequence, and

wherein thermocycling comprises:

i. denaturing the target nucleic acid sequence; and

ii. annealing of the forward and reverse oligonucleotide primers; and

iii. extension of the target nucleic acid sequence by the forward and reverse oligonucleotide primers,

c. simultaneously detecting the amplified target nucleic acid sequence during said amplifying step.

2. The real-time dynamic flux method of nucleic acid sequence amplification of claim 1 , wherein detecting occurs by monitoring fluorescence.

3. The real-time dynamic flux method of nucleic acid sequence amplification of claim 1 , wherein detecting occurs by monitoring fluorescence of a fluorescent dye that intercalates with double-stranded DNA.

4. The real-time dynamic flux method of nucleic acid sequence amplification of claim 1 , wherein detecting occurs by monitoring fluorescence of a sequence-specific oligonucleotide probe labelled with a fluorescent reporter.

5. The real-time dynamic flux method of nucleic acid sequence amplification of claim 1 , wherein amplifying the target nucleic acid sequence by thermocycling the pair of forward and reverse oligonucleotide primers and the target nucleic acid sequence occurs within a 10° C. temperature range.

6. The real-time dynamic flux method of nucleic acid sequence amplification of claim 1 , wherein amplifying the target nucleic acid sequence by thermocycling the pair of forward and reverse oligonucleotide primers and the target nucleic acid sequence occurs within a 5° C. temperature range.

7. The real-time dynamic flux method of nucleic acid sequence amplification of claim 1 , wherein amplifying the target nucleic acid sequence by thermocycling the pair of forward and reverse oligonucleotide primers and the target nucleic acid sequence occurs within a 2.5° C. temperature range.

8. The real-time dynamic flux method of nucleic acid sequence amplification of claim 1 , wherein amplifying the target nucleic acid sequence by thermocycling the pair of forward and reverse oligonucleotide primers and the target nucleic acid sequence occurs within a 2.5° C. to 10° C. temperature range around the melting temperature of the target nucleic acid sequence.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE THE RECEIVING PARTY NAME PREVIOUSLY RECORDED AT REEL: 055828 FRAME: 0971. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Feb 13, 2023
From: FLUORESENTRIC, INC.
To: XCR DIAGNOSTICS, INC.
Reel/Frame 063601/0176 →
MERGER Recorded Apr 5, 2021
From: FLUORESENTRIC, INC.
To: XCR DIAGNOSTIC, INC.
Reel/Frame 055828/0971 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2018
From: SIGNAL DIAGNOSTICS, INC.
To: FLUORESENTRIC, INC.
Reel/Frame 047109/0344 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 29, 2017
From: CAPLIN, BRIAN ERICH
To: SIGNAL DIAGNOSTICS, INC.
Reel/Frame 044507/0265 →
Continuity (6)
Continuation 15138517 · Apr 26, 2016
Division 14825364 · Aug 13, 2015
Continuation 12951710 · Nov 22, 2010
Continuation 12058637 · Mar 28, 2008
Provisional Application 60908604 · Mar 28, 2007
Related Publication 20170226576A1 · Aug 10, 2017